134 related articles for article (PubMed ID: 34865381)
21. Detection of
Yao YL; Wang XG; Zhao XL; Li SQ; Zhou YJ; Xu YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):309-313. PubMed ID: 35351263
[TBL] [Abstract][Full Text] [Related]
22. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
[No Abstract] [Full Text] [Related]
23. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
[TBL] [Abstract][Full Text] [Related]
24. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
[TBL] [Abstract][Full Text] [Related]
25. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
Kanagal-Shamanna R; Jain P; Takahashi K; Short NJ; Tang G; Issa GC; Ravandi F; Garcia-Manero G; Yin CC; Luthra R; Patel KP; Khoury JD; Montalban-Bravo G; Sasaki K; Kadia TM; Borthakur G; Konopleva M; Jain N; Garris R; Pierce S; Wierda W; Estrov Z; Cortes J; O'Brien S; Kantarjian HM; Jabbour E
Cancer; 2017 Oct; 123(19):3717-3724. PubMed ID: 28608976
[TBL] [Abstract][Full Text] [Related]
26. Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia.
Itzykson R; Duployez N; Fasan A; Decool G; Marceau-Renaut A; Meggendorfer M; Jourdan E; Petit A; Lapillonne H; Micol JB; Cornillet-Lefebvre P; Ifrah N; Leverger G; Dombret H; Boissel N; Haferlach T; Preudhomme C
Blood; 2018 Jul; 132(2):187-196. PubMed ID: 29692343
[TBL] [Abstract][Full Text] [Related]
27. Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.
Saygin C; Zhang P; Stauber J; Aldoss I; Sperling AS; Weeks LD; Luskin MR; Knepper TC; Wanjari P; Wang P; Lager AM; Fitzpatrick C; Segal JP; Gharghabi M; Gurbuxani S; Venkataraman G; Cheng JX; Eisfelder BJ; Bohorquez O; Patel AA; Umesh Nagalakshmi S; Jayaram S; Odenike OM; Larson RA; Godley LA; Arber DA; Gibson CJ; Munshi NC; Marcucci G; Ebert BL; Greally JM; Steidl U; Lapalombella R; Shah BD; Stock W
Blood Cancer Discov; 2024 May; 5(3):164-179. PubMed ID: 38150184
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Fedullo AL; Messina M; Elia L; Piciocchi A; Gianfelici V; Lauretti A; Soddu S; Puzzolo MC; Minotti C; Ferrara F; Martino B; Chiusolo P; Calafiore V; Paolini S; Vignetti M; Vitale A; Guarini A; Foà R; Chiaretti S
Haematologica; 2019 Feb; 104(2):312-318. PubMed ID: 30190342
[TBL] [Abstract][Full Text] [Related]
29. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
[TBL] [Abstract][Full Text] [Related]
31.
Bond J; Touzart A; Leprêtre S; Graux C; Bargetzi M; Lhermitte L; Hypolite G; Leguay T; Hicheri Y; Guillerm G; Bilger K; Lhéritier V; Hunault M; Huguet F; Chalandon Y; Ifrah N; Macintyre E; Dombret H; Asnafi V; Boissel N
Haematologica; 2019 Aug; 104(8):1617-1625. PubMed ID: 30655366
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen.
Ou J; Xu X; Deng S; Liang H; Cai Z; Li J; Huang Z; Tang B; Wang Z; Zhou Y; Liu X; Liu Q; Zhou H
Leuk Lymphoma; 2024 Feb; 65(2):219-227. PubMed ID: 37938093
[TBL] [Abstract][Full Text] [Related]
33. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
34. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
35. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
[TBL] [Abstract][Full Text] [Related]
36. [Multicenter clinical trial of acute lymphoblastic leukemia in elder children and adolescents].
Zhang N; Shen SH; Wang NL; Li H; Yang JW; Shao JP; Jiang H; Tang JY
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):717-723. PubMed ID: 30369180
[No Abstract] [Full Text] [Related]
37. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
[TBL] [Abstract][Full Text] [Related]
38. Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.
Ebeid EN; Kamel MM; Ali BA
J Egypt Natl Canc Inst; 2008 Jun; 20(2):127-33. PubMed ID: 20029468
[TBL] [Abstract][Full Text] [Related]
39. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
